The relationship between epidermal growth factor levels in breast milk with fecal interleukin-8 on neonates

Resti N  Rahayu; Anik Puryatni; Husnul Khotimah

doi:10.30574/gscbps.2020.11.2.0060

Authors

Resti N Rahayu Master Program of Biomedical Sciences, Faculty of Medicine, Universitas Brawijaya, Indonesia.
Anik Puryatni Department of Pediatrics, Saiful Anwar Hospital, Malang, Universitas Brawijaya, Indonesia.
Husnul Khotimah Department of Pharmacology, Faculty of Medicine, Universitas Brawijaya, Indonesia.

DOI:

https://doi.org/10.30574/gscbps.2020.11.2.0060

Keywords:

Epidermal growth factor, Fecal Interleukin-8, Breast milk, Neonates

Abstract

Breast milk contains several active biological components such as epidermal growth factor (EGF). Colostrum breast milk have much biological components than mature breast milk. Endogenous infection only increases the level of fecal IL-8. However, study that discusses the relationship between breast milk EGF and IL-8 cytokine inside neonate digestive system is not yet present. Thus, this study aimed to discover the relationship of EGF in the breast milk process stage—from the colostrum to the transitional, and the fecal Interleukin-8 inflammatory cytokine on neonates. There were 24 neonates that categorized into four study sample groups (atterm neonates, mild preterm neonates, very preterm neonates, and extremely preterm neonates). The EGF level in the breast milk was gained from neonate age of 3^rd day for colostrum breast milk and 10^th day for transitional breast milk from both preterm and atterm neonates. Based on ANOVA test, the mean EGF of atterm neonate colostrum milk was higher (776,25 ± 877; p = 0,0013) compared to the preterm neonate, and so was the mean EGF of atterm neonate transitional milk (645,48 ± 296; p = 0,0001). Statistical test using Pearson test and Bartlett’s test indicated a relationship (p=0.000) and r = - 0.4207 that showed negative correlation between EGF level in breastmilk with IL-8 fecal neonates.

Metrics

Metrics Loading ...

References

Tanner SM, Beryhill Ellenburg JL, Jilling T, Cleveland DS, Lorenz RG and Martin CA. (2015). Pathogenesis of Necrotizing Enterocolitis: Modeling the Innate Immune Response. The American Journal of Pathology, 185(1), 1—13.

University of California San Fransisco (UCFS). (2014). Preterm birth is now the leading cause of death in young children globally. California Preterm Birth Initiative.

Krisnaldi. (2009). Persalinan Prematur. Jakarta: Penerbit Buku Kedokteran EGC.

Gila-Diaz A, Arribas SM, Algara A, Martín-Cabrejas MA, López de Pablo ÁL, Sáenz de Pipaón M and Ramiro-Cortijo D. (2019). A Review of Bioactive Factors in Human Breastmilk: A Focus on Prematurity. Nutrients Journal.

Carlson J, Chang MI, Nandivada P, Cowan E and Puder M. (2013). Neonatal intestinal physiology and failure. Seminars in Pediatric Surgery, 22, 190–194.

Riksani. (2012). Keajaiban ASI (Air Susu Ibu). Jakarta: Dunia Sehat.

Grave GD, Nelson SA, Walker WA, Moss RL, Dvorak B, Hamilton FA, Higgins R and Raju TN. (2007). New Therapies and Preventive Approaches For Necrotizing Enterocolitis: Report Of A Research Planning Workshop. Pediatric Research, 62, 510-514.

Beswick EJ and Reyes VE. (2008). Macrophage migration inhibitory factor and interleukin-8 produced by gastric epithelial cells during Helicobacter pylori exposure induce expression and activation of the epidermal growth factor receptor. Infect Immun. 76(7), 3233-40.

Westerbeek EAM, Mørch HNL, Fetter WPF, Twisk JWR and Van Elburg RM. (2011). Effect of Neutral and Acidic Oligosaccharides on Fecal IL-8 and Fecal Calprotectin in Preterm Infants. Pediatric Research, 69(3).

Gupta A, Lakhoo K, Pritchard N and Herbert M. (2007). Epidermal Growth Factor in Neonatal Saliva. European journal pediatric surgery, 18, 245 – 24.

Lu Jiang, Wu K and Li D. (2018). Epidermal Growth Factor and Transforming Growth Factor-α in Human Milk of Different Lactation Stages and Different Regions and Relationship with Maternal Diet. Food Funct.

Raymond, J Playford, Chritopher E Macdonald and Wendy S Johnson. (2000). Colostrum and Milk-Derived Peptide Growth Factors for The Treatment of Gastrointestinal Disorders. American Society for Clinical Nutrition.

Kobata R, Tsukahara H, Oshima Y, Ohta N, Tokuriki S, Tamura S and Mayumi M. (2007). High level of growth factors in human breast milk. Elsevier Ireland.

Jijon HB, Buret A, Hirota CL, Hollenberg MD and Beck PL. (2012). The EGF Receptor and HER2 Participate in TNF-α-Dependent MAPK Activation and IL-8 Secretion in Intestinal Epithelial Cells. Hindawi Publishing Corporation Mediators of Inflammation.